Our top pick for
BRP Group, Inc is an insurance brokers business based in the US. BRP Group shares (BRP) are listed on the NASDAQ and all prices are listed in US Dollars. BRP Group employs 800 staff and has a trailing 12-month revenue of around USD$207.8 million.
|52-week range||USD$8.35 - USD$33.56|
|50-day moving average||USD$26.9265|
|200-day moving average||USD$27.656|
|Wall St. target price||USD$33|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||USD$0.13|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Valuing BRP Group stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of BRP Group's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
BRP Group's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 1387x. In other words, BRP Group shares trade at around 1387x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
BRP Group's EBITDA (earnings before interest, taxes, depreciation and amortisation) is USD$23 million.
The EBITDA is a measure of a BRP Group's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||USD$207.8 million|
|Operating margin TTM||2.81%|
|Gross profit TTM||USD$42.2 million|
|Return on assets TTM||0.68%|
|Return on equity TTM||-25.52%|
|Market capitalisation||USD$3.2 billion|
TTM: trailing 12 months
There are currently 981,499 BRP Group shares held short by investors – that's known as BRP Group's "short interest". This figure is 12.4% up from 872,875 last month.
There are a few different ways that this level of interest in shorting BRP Group shares can be evaluated.
BRP Group's "short interest ratio" (SIR) is the quantity of BRP Group shares currently shorted divided by the average quantity of BRP Group shares traded daily (recently around 348049.29078014). BRP Group's SIR currently stands at 2.82. In other words for every 100,000 BRP Group shares traded daily on the market, roughly 2820 shares are currently held short.
However BRP Group's short interest can also be evaluated against the total number of BRP Group shares, or, against the total number of tradable BRP Group shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case BRP Group's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 BRP Group shares in existence, roughly 10 shares are currently held short) or 0.0168% of the tradable shares (for every 100,000 tradable BRP Group shares, roughly 17 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against BRP Group.
Find out more about how you can short BRP Group stock.
We're not expecting BRP Group to pay a dividend over the next 12 months.
BRP Group, Inc. operates as an insurance distribution company in the United States and internationally. The company operates through four segments: Middle Market, Specialty, MainStreet, and Medicare. The Middle Market segment provides private risk management, commercial risk management, and employee benefits solutions for mid-to-large size businesses and high net worth individuals and families. The Specialty segment operates as a wholesale co-brokerage platform that delivers programs requiring underwriting and placement services. The MainStreet segment offers personal, commercial, and life and health solutions to individuals and businesses in their communities. The Medicare segment provides consultation for government assistance programs and solutions to seniors and individuals through a network of agents. The company was founded in 2011 and is headquartered in Tampa, Florida.
Everything we know about the Achilles Therapeutics plc IPO, plus information on how to buy in.
Everything we know about the SEMrush Holdings Inc IPO, plus information on how to buy in.
Everything we know about the ChargePoint IPO, plus information on how to buy in.
Everything we know about the Kaltura Inc IPO, plus information on how to buy in.
Everything we know about the Rocket Lab IPO, plus information on how to buy in.
Everything we know about the Soho House IPO, plus information on how to buy in.
Everything we know about the VIZIO IPO, plus information on how to buy in.
Everything we know about the IDW Media Holdings Inc IPO, plus information on how to buy in.
Everything we know about the Karooooo Ltd IPO, plus information on how to buy in.
Everything we know about the Connect Biopharma Holdings Limited IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.